SCHEMBL7128260

SCHEMBL7128260

CCOC(=O)c1c(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)sc2c1CCCC2

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.63
TP53 P04637 3/20 0.63
ALDH1A1 P00352 5/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
LMNA P02545 2/20 0.62
POLB P06746 1/20 0.62
HPGD P15428 5/20 0.60
HSD17B10 Q99714 5/20 0.60
KDM4E B2RXH2 4/20 0.60
USP2 O75604 1/20 0.60
TSHR P16473 1/20 0.60
CNR2 P34972 2/20 0.58
CNR1 P21554 1/20 0.58
RXFP1 Q9HBX9 1/20 0.57
MAPK1 P28482 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3811334 0.89 MAPT (0.63) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL3987431 0.85 MAPT (0.67) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL16562060 0.85 MAPT (0.74) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL3914153 0.85 MEN1 (0.66) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL17194232 0.80 MAPT (0.62) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL329961 0.79 MAPT (0.70) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL3990046 0.79 ALDH1A1 (0.60) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL13964421 0.79 CNR2 (0.69) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL1913812 0.79 CNR2 (0.66) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL18104300 0.78 MEN1 (0.77) MAPTTP53ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885TP53 3029/4885ALDH1A1 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.